FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology, virology and medicine. There is offered application of a vaccine containing double-stranded RNA, including Poly (I:C), and a mucosal influenza virus antigen.
EFFECT: invention ensures easy influenza virus vaccination.
10 cl, 10 tbl, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NASAL INFLUENZA VACCINE COMPOSITION | 2013 |
|
RU2652296C2 |
| MEDICINAL ANTIGEN CARRIER ENABLING TRANSMUCOSAL AND TRANSDERMAL ADMINISTRATION, METHOD OF MUCOSAL IMMUNITY INDUCTION, MUCOSAL VACCINE AND RELATED DRUG DELIVERY SYSTEM | 2005 |
|
RU2396090C2 |
| SECRETORY IgA AND IgG ANTIBODY INDUCER | 2006 |
|
RU2440138C2 |
| RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2802058C1 |
| VACCINES WITH LTB ADJUVANT | 1998 |
|
RU2211050C2 |
| VACCINES AND METHODS OF TREATING CANINE INFLUENZA | 2006 |
|
RU2396976C2 |
| FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs) | 2006 |
|
RU2483751C2 |
| INFLUENZA INFECTING DOGS AND USE THEREOF | 2014 |
|
RU2711807C2 |
| VACCINE COMPOSITION | 2013 |
|
RU2655627C2 |
| INFLUENZA HAEMAGGLUTININ AND NEURAMINIDASE VARIANTS | 2010 |
|
RU2535970C2 |
